跳至主要内容
临床试验/NCT00976274
NCT00976274已完成不适用

Effects of Korean Red Ginseng on Cardiovascular Risks in Subjects With Metabolic Syndrome

The Korean Society of Ginseng2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2009年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
2
主要终点
Change in the Pre- and Post-treatment Systolic Blood Pressure

研究概览

简要总结

Five factor consisting of Metabolic syndrome is closely linked by insulin resistance. Until now, several studies have been performed about effects of Korea red ginseng on hypertension, diabetes, and hyperlipidemia, but not metabolic syndrome.

The investigators hypothesize that Korean red ginseng could improve each constituents of metabolic syndrome, arterial stiffness, and inflammatory markers.

The aim of this study is to determine effects of Korean red ginseng on cardiovascular risks in subjects with metabolic syndrome.

详细描述

The details of study objective are followed by these:

  • comparison of blood pressure before and after Korean red ginseng administration
  • comparison of metabolic indicator before and after Korean red ginseng administration
  • comparison of oxidative stress and inflammatory markers before and after Korean red ginseng administration
  • comparison of arterial stiffness before and after Korean red ginseng administration

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • (three or more of following five factors)
  • waist circumference(male: more than 90cm, female: more than 80cm)
  • blood pressure(systolic: more than 130mmHg, diastolic: more than 85mmHg)
  • fasting plasma glucose: more than 100mg/dL
  • fasting triglycerides: more than 150mg/dL
  • High-density lipoprotein(HDL)-cholesterol(male: less than 40mg/dL, female: less than 50mg/dL)

排除标准

  • (any one of following factors)
  • uncontrolled blood pressure(systolic: more than 160mmHg, diastolic: more than 100mmHg) or subjects taking blood pressure lowering drug
  • Type 2 diabetes patients or fasting plasma glucose more than 126mg/dL
  • triglyceride more than 400mg/dL, total cholesterol more than 250mg/dL
  • subjects taking antilipidemic drug
  • past history of coronary heart disease or cerebrovascular disease

结局指标

主要结局

Change in the Pre- and Post-treatment Systolic Blood Pressure

时间窗: baseline and 12 weeks

次要结局

  • Change in the Pre- and Post-treatment Oxidized Low-densty Lipoprotein(LDL)(baseline and 12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jae-Yong Shim

Professor

The Korean Society of Ginseng

研究点 (2)

Loading locations...

相似试验